Evidence map›Paper›PMID 42553877›Full record

ArticleJournal of the Canadian Association of Gastroenterology2026

Nationalization of clinical care pathways for inflammatory bowel disease management in Canada.

Kaitlyn Delaney Chappell, Aalia Tausif, Cynthia H Seow, Remo Panaccione, Allen Lim, Claudia Tersigni, Geoffrey C Nguyen, Haili Wang, Wendy Fehr, Alain Bitton and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Kaitlyn Delaney ChappellDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.ORCID https://orcid.org/0000-0001-6695-7305
Aalia TausifPromoting Access and Care through Centres of Excellence, Crohn's and Colitis Canada, Toronto, ON M5G 1Y8, Canada.
Cynthia H SeowDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB M5G 1Y8, Canada.ORCID https://orcid.org/0000-0002-1551-9054
Remo PanaccioneDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB M5G 1Y8, Canada.ORCID https://orcid.org/0000-0002-5247-940X
Allen LimGastroenterology, Alberta Health Services, Edmonton, AB T5J 3E4, Canada.
Claudia TersigniSchulich School of Medicine and Dentistry Western University, London, ON N6A 5C1, Canada.
Geoffrey C NguyenDepartment of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.ORCID https://orcid.org/0000-0001-7083-7429
Haili WangDivision of General Surgery, Department of Surgery, University of Alberta, Edmonton, AB T6G 2B7, Canada.
Wendy FehrSaskatchewan Health Authority, Saskatchewan Health Authority, SK S7K 0M7, Canada.
Alain BittonMcGill University Health Centre, McGill University, Montreal, QC H4A 0B1, Canada.
Clare McCabe-WoodrowPromoting Access and Care through Centres of Excellence, Crohn's and Colitis Canada, Toronto, ON M5G 1Y8, Canada.
Frank HoentjenPromoting Access and Care through Centres of Excellence, Crohn's and Colitis Canada, Toronto, ON M5G 1Y8, Canada.
Irina NistorMedicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Jesse SiffledeenPromoting Access and Care through Centres of Excellence, Crohn's and Colitis Canada, Toronto, ON M5G 1Y8, Canada.
Jennifer deBruynDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB M5G 1Y8, Canada.
Jeffrey McCurdyDivision of Gastroenterology, Department of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID https://orcid.org/0000-0002-0658-3062
Nancy FuDivision of Gastroenterolgy, Department of Medicine, University of British Columbia, Vancouver, BC V5Z1M9, Canada.ORCID https://orcid.org/0000-0002-1752-8659
Neeraj NarulaDivision of Gastroenterolgy, Department of Medicine, McMaster University, Hamilton, ON L8N3Z5, Canada.ORCID https://orcid.org/0000-0002-1536-8436
Natasha BollegalaDepartment of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.
Sharyle FowlerDepartment of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada.ORCID https://orcid.org/0000-0002-2721-1591
Sanjay MurthyDivision of Gastroenterology, Department of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Seth R ShafferDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, R3A 1R9, Canada.ORCID https://orcid.org/0000-0002-9872-6832
Vivian HuangDepartment of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.ORCID https://orcid.org/0000-0002-4524-9403
Yvette LeungDivision of Gastroenterolgy, Department of Medicine, University of British Columbia, Vancouver, BC V5Z1M9, Canada.
Kate LeeDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.
Jacqueline de GuzmanDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.
Karen I KroekerPromoting Access and Care through Centres of Excellence, Crohn's and Colitis Canada, Toronto, ON M5G 1Y8, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory Bowel Diseases (IBD) are challenging conditions to manage due to the heterogeneity of the disease, diverse treatment options, and nuances of care over a range of ages. Clinical care pathways (CCPs) developed by experts enable health care providers (HCPs) to deliver standardized, high-quality, evidence-based care. In order to remain useful and valuable, these pathways need to evolve alongside changing treatment recommendations. Standardizing IBD care is a priority of Crohn's Colitis Canada's Promoting Access and Care through Centres of Excellence (PACE) network. Aim: To describe the process of nationalizing IBD CCP's, including development, standardization, maintenance, and dissemination. Methods: This project was based on a previously developed structured framework for review and maintenance. The CCP team consisted of a leadership group, advisory council and a working group with diverse representation from the country and areas of expertise. The work was tracked with a database with coordination completed by staff of the national organization. Results: The nationalization process lasted 14 months, with input from 23 HCPs from 14 academic and community institutions across Canada. Sixteen CCPs for IBD care were developed and approved by the CCP team. Challenges encountered included outdated guidelines, differing clinical opinions, and busy clinical schedules of the team members. Translation into French is complete. Support of Crohn's and Colitis Canada was invaluable. Conclusion: Despite anticipated challenges, 16 CCPs received approval from the advisory council and are publicly available to HCPs across Canada. Our approach to this undertaking and the lessons learned may be valuable for experts undertaking similar projects for patients with chronic diseases.

Indexed as

clinical care pathways (CCPs)clinical practice guidelinesinflammatory bowel disease (IBD)nationalization

Identifiers

PMID42553877
PMCPMC13436821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.